|
The CONSERVE® PLUS has the
largest regulated clinical trial for resurfacing
ever performed in the US, with more than 1300
patients enrolled. To date, the overall
survivorship of CONSERVE® PLUS implants is 97%.
Almost all the patients enrolled in the study
have returned to their active lifestyles without
pain. |
 |
The CONSERVE® PLUS implant is a wonderful
option to total hip replacement. It contains no plastic
parts and allows patients to maintain their active
lifestyles. Advantages include:
These advantages have been cited by
Dr. Harlan Amstutz in the abstract "Advantages of
Metal-on-Metal Hybrid Resurfacing (CONSERVE® PLUS)",
which he presented in January 2004.
In the CONSERVE® PLUS study, the dislocation
rate was 0.9% (or 13 in 1305) This is far lower than the
traditional dislocation rates for total hip arthroplasty.
Many studies have pointed to primary hip dislocation rates
ranging from 2-5%.
The Wright Conserve Plus right offers 11 femoral head
options compared to 6 by Smith & Nephew (BHR) and 5 by Corin
(CORMET). The CONSERVE® PLUS femoral heads are also
available in 2mm increments as compared to others than use
4mm increments. This greater range of sizes allows for
better patient matching and more bone conservation.
The CONSERVE® PLUS metal-on-metal
articulation has a good clinical history with over 6 years
and over 1300 patients. The paper presenting the
clinical results of the first 400 CONSERVE® PLUS hip
resurfacing cases performed at the JRI has been accepted for
publication by the Journal of Bone and Joint
Surgery.
|
